A disadvantage of our study design is that half of the patients receive radiation of the 3D-scan, while they cannot benefit from this 3D-scan.
Especially in a screening setting - where the majority of participants does not benefit from the scan - participants will give a substantial weight to pain and burden compared with symptomatic patients who are much more likely to benefit from the scan.
But the Centers for Medicare and Medicaid Services, in the final decision, said there remained "uncertainty regarding any potential health benefits" from the scans and described the existing evidence as of "overall limited quality and limited applicability".
The 5-year survival benefit from MUGA scanning had minimal variation for all tested levels for all age groups.
Medical fields that could benefit from the 3D scanning tech include orthotics, prosthetics and plastic surgery, it added.
Small radiation dose reductions are still achievable with the use of model-based iterative reconstruction techniques [28], but most of the benefit from reduced kV scanning in the presence of AEC in CTA comes from improved vessel contrast.
Our system shows that it is possible to identify patients who will benefit from scanning within 24 h of referral.
Furthermore, the effects of age and cumulative dose seemed to be additive, which further emphasized that patients who are younger than 40 and are given ⩽350 mg m−2 of Dox are the least likely to benefit from pretreatment MUGA scanning.
Many other cardiologists, though, say patients like Mr. Ring do not benefit from CT scans.
Again, there was minimal variation in the modest clinical benefit from MUGA scan monitoring for all age groups.
